Clinical trial · Interventional
Evaluation of Early Home Return in Patients With Enucleation of Prostate Adenoma
Evaluation of Early Home Return Care Pathway in Patients Who Have Undergone Endoscopic Enucleation of Prostate Adenoma by Laser
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prostate adenoma management includes, if necessary, surgical treatments: resection or vaporization by endoscopy or by open surgery in case of a very large prostate. Laser technology is a curative treatment for prostate adenoma. The minimum duration of hospitalization, in the context of enucleation prostatic endoscopy by laser, is estimated at 48 hours. The Union Clinique has developed an improved rehabilitation care pathway reducing hospitalization duration to 24 hours (one night hospitalization). This care pathway involves patient as an actor in its care but also health professionals, in particular nurses. This study is based on the hypothesis that the model developed by the Union Clinique can be translated to other healthcare establishments and that home return supervized by nurses allows reducing hospital stay length without increasing the risk of serious complications for patients
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adenoma | Adenoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Patient support | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Early home return arm
- description
- Nurses will coordinate the patients' care prior to their intervention and when they leave the Clinics.
- interventionNames
- Other: Patient support
- type
- NO_INTERVENTION
- label
- Standard Of Care arm
- description
- Patients will not receive any support before and after intervention and hospital leave
Primary outcomes (1)
- measure
- Re-hospitalizations and/or hospitalization extensions rate
- timeFrame
- 2 weeks
- description
- the percentage of re-hospitalizations and/or hospitalization extensions
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * Patient planned for endoscopic enucleation of prostate adenoma with laser * Patient with symptomatic benign prostatic hyperplasia and refractory to medical reatment and/or * Patient with benign prostatic hyperplasia complicated by chronic retention of urine and/or * Patient with benign prostatic hyperplasia complicated by prostatitis and/or * Patient with symptomatic benign prostatic hyperplasia Exclusion Criteria: * Patient living beyond the scope of care by the nurses coordination * Bedridden patient or WHO clinical condition \>2 * Patient requiring curative anticoagulation which cannot be interrupted or relayed at home by heparin * Patient with double anti-platelet aggregation who cannot be interrupted
References
Publications (0)
Data not yet available